Jade Biosciences, Inc. (JBIO) vs QuidelOrtho Corporation (QDEL)
A side-by-side comparison of Jade Biosciences, Inc. and QuidelOrtho Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
JBIO
Jade Biosciences, Inc.
$13.26HealthcareDelayed quote: Oct 6, 2026, 3:50 PM EDT
QDEL
QuidelOrtho Corporation
$12.72HealthcareDelayed quote: Oct 6, 2026, 3:50 PM EDT
Total return — JBIO vs QDEL
growth of $100 · dividends reinvested · last 5yJBIO -97.8% (-53.5%/yr)QDEL -90.5% (-37.6%/yr)QDEL compounded faster over this window
JBIO QDEL
JBIO vs QDEL: by the numbers
- •QDEL is the larger company ($867M vs $807M market cap).
- •Both run net losses; JBIO's is the smaller (0.00% vs -39.20% net margin).
Metrics side by side
Valuation
| Metric | JBIO | QDEL |
|---|---|---|
| Forward P/E | N/A | 16.46 |
| P/S ratio | N/A | 0.32 |
| P/B ratio | 1.83 | 0.49 |
Profitability
| Metric | JBIO | QDEL |
|---|---|---|
| Gross margin | 0.00% | 44.60% |
| Operating margin | 0.00% | -30.67% |
| Net margin | 0.00% | -39.20% |
| ROE | -34.83% | -59.07% |
| ROIC | -37.39% | -16.05% |
Growth (annualized)
| Metric | JBIO | QDEL |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 7.14% |
| Total return CAGR (5Y) | -52.65% | -38.12% |
Frequently asked
- How have JBIO and QDEL total returns compared?
- Over the past 5 years, JBIO delivered -52.65% and QDEL delivered -38.12% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.